Success in meeting new rules and regulations and benchmarks in population health management and medical research all depend on providers' ability to cull information from patient records.
Embattled blood testing company Theranos has agreed to pay $4.65 million to cover full refunds for every Arizona customer who used the company's testing services, Arizona Attorney General Mark Brnovich announced Tuesday.
Noom, a New York-based company whose app helps users lose weight, is the first program to achieve full recognition for diabetes prevention from the federal Centers for Disease Control and Prevention.
U.S. healthcare spending, which in 2015 hit nearly $10,000 for every person in the country, was 29% higher than the next most expensive country, Luxembourg.
What's black and white and might help humans regenerate their eyes all over? The tiny zebra fish. While only a few centimeters long, the freshwater minnow native to the Himalayan region is capable of amazing feats of regeneration. When their hearts, brains, fins or eyes are damaged, they...
Tech billionaire Elon Musk, whose ventures have ranged from building sleek electric cars to sponsoring space missions, is launching tech startup Neuralink to focus on linking brains to computers.
A federal watchdog group said HHS isn't doing enough to measure how much patients use their medical records.
Thomas Meade, serial entrepreneur, is on to his fourth venture, Ohmx, a 20-employee company in Evanston, Illinois, that is developing electronic handheld devices to detect proteins such as those generated from heart attacks
How health systems must better prepare and take action to avoid the costly problem of retained surgical items (RSI's).
Complications from warfarin can be serious. According to one study published in 2011, it is implicated in 33% of adverse drug events in patients 65 or older, and nearly all of those events are from unintentional overdoses.
The role of 3-D printing in transforming the practice of radiology will be highlighted during the Radiological Society of North America's annual meeting in Chicago, which runs through Dec. 1.
A serious commitment to “doubling the pace” of progress will require the public and private sectors to consider doubling investments in medical research to about $1,000 per American per year to find the solutions to what ails us.